{"title":"Co-Existence of Relapsing Remitting Multiple Sclerosis and HLA B27 PositiveAnkylosing Spondylitis in a Malay Male: A Rare Occurrence","authors":"S. Viswanathan, Kamil Mkm","doi":"10.4172/2376-0389.1000198","DOIUrl":null,"url":null,"abstract":"Ankylosing spondylitis (AS) and multiple sclerosis (MS) are two different chronic inflammatory autoimmune conditions with unclear etiopathogenesis. One is a rheumatological disorder while the other is a neurological one. Current literature on an association between these two conditions is limited. Furthermore, early recognition of potential cases with both conditions co-existing is important as there have been very rare reports on the occurrence of demyelinating diseases or unmasking of latent MS in patients with ankylosing spondylitis treated with anti-TNFα. This has important therapeutic implications for patients at such risk.","PeriodicalId":16369,"journal":{"name":"Journal of multiple sclerosis","volume":"33 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of multiple sclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2376-0389.1000198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Ankylosing spondylitis (AS) and multiple sclerosis (MS) are two different chronic inflammatory autoimmune conditions with unclear etiopathogenesis. One is a rheumatological disorder while the other is a neurological one. Current literature on an association between these two conditions is limited. Furthermore, early recognition of potential cases with both conditions co-existing is important as there have been very rare reports on the occurrence of demyelinating diseases or unmasking of latent MS in patients with ankylosing spondylitis treated with anti-TNFα. This has important therapeutic implications for patients at such risk.